Famotidine
Famotidine is a pharmaceutical drug with 80 clinical trials. Currently 10 active trials ongoing. Historical success rate of 84.1%.
Success Metrics
Based on 53 completed trials
Phase Distribution
Phase Distribution
41
Early Stage
19
Mid Stage
14
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
81.5%
53 of 65 finished
18.5%
12 ended early
10
trials recruiting
80
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study to Learn How Different Preparations of Osivelotor Taste and Enter the Blood With Food or Liquids or With an Antacid in Healthy Adults
A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease
I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients
Prevention of Post-Cardiac Surgery Acute Kidney Injury by Proton Pump Inhibitor
Evaluating Premedication Regimens (Methylprednisolone vs Dexamethasone-based) for the Prevention of Systemic and Injection Site Reactions to Motixafortide in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization, PARADE Trial
Clinical Trials (80)
A Study to Learn How Different Preparations of Osivelotor Taste and Enter the Blood With Food or Liquids or With an Antacid in Healthy Adults
A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease
I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients
Prevention of Post-Cardiac Surgery Acute Kidney Injury by Proton Pump Inhibitor
Evaluating Premedication Regimens (Methylprednisolone vs Dexamethasone-based) for the Prevention of Systemic and Injection Site Reactions to Motixafortide in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization, PARADE Trial
Elotuzumab in Immunoglobulin G4-Related Disease (IgG4-RD)
A Phase I/II Study of Intraperitoneal Paclitaxel in Patients With Metastatic Appendiceal Adenocarcinoma
Gastrointestinal Dysmotility on Aspiration Risk
LEAP-CT for Treatment of COVID-19 Patients (Master Protocol)
T Cell Receptor Gene Therapy Targeting KK-LC-1 for Gastric, Breast, Cervical, Lung and Other KK-LC-1 Positive Epithelial Cancers
A Study to Assess the Effect of Itraconazole, Rifampin, and Acid-Reducing Agents on INCB161734 Pharmacokinetics When Administered Orally in Healthy Participants
A Phase II Study of Perioperative Paclitaxel in Patients With Gastric Adenocarcinoma and Carcinomatosis or Positive Cytology
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of INCB160058 When Administered Orally to Healthy Adult Participant
Effect of Tegoprazan for Elective Surgery Patients Under General Anesthesia
Safely Stopping Pre-medications in Patients With Breast Cancer Who Are Receiving Paclitaxel
Moxetumomab Pasudotox-tdfk (Lumoxiti(TM)) and Either Rituximab (Rituxan(R)) or Ruxience for Relapsed Hairy Cell Leukemia
Initiation of Acid Suppression Therapy Prospective Outcomes for Laryngomalacia
Treatment of Long CoronaVirus Disease (COVID) (TLC) Feasibility Trial
Multimodal Pain Package vs. Regular Formulation for Pain Management in Ambulatory Spinal Surgery
A Study to Prevent Infantile Spasms Relapse
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 80